APA (7th ed.) Citation

Boggs, D. L., Surti, T., Gupta, A., Gupta, S., Niciu, M., Pittman, B., . . . Ranganathan, M. (2018). The effects of cannabidiol (CBD) on cognition and symptoms in outpatients with chronic schizophrenia a randomized placebo controlled trial. Psychopharmacology, 235(7), 1923. https://doi.org/10.1007/s00213-018-4885-9

Chicago Style (17th ed.) Citation

Boggs, Douglas L., et al. "The Effects of Cannabidiol (CBD) on Cognition and Symptoms in Outpatients with Chronic Schizophrenia a Randomized Placebo Controlled Trial." Psychopharmacology 235, no. 7 (2018): 1923. https://doi.org/10.1007/s00213-018-4885-9.

MLA (9th ed.) Citation

Boggs, Douglas L., et al. "The Effects of Cannabidiol (CBD) on Cognition and Symptoms in Outpatients with Chronic Schizophrenia a Randomized Placebo Controlled Trial." Psychopharmacology, vol. 235, no. 7, 2018, p. 1923, https://doi.org/10.1007/s00213-018-4885-9.